A 35-year-old woman with taxane and anthracycline-resistant recurrent breast cancer with multiple lung metastasis and carcinomatous lymphangitis was treated with CMF as third-line chemotherapy. A complete response was achieved,and the toxicities were tolerable. We thought that CMF could be a useful regimen as third-line chemotherapy for metastatic breast cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2217/14750708.3.3.365 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!